These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
376 related articles for article (PubMed ID: 2836473)
21. Effects of antagonists of growth hormone-releasing hormone (GHRH) on GH and insulin-like growth factor I levels in transgenic mice overexpressing the human GHRH gene, an animal model of acromegaly. Kovacs M; Kineman RD; Schally AV; Zarandi M; Groot K; Frohman LA Endocrinology; 1997 Nov; 138(11):4536-42. PubMed ID: 9348175 [TBL] [Abstract][Full Text] [Related]
22. Correlative studies between the presence of thyrotropin-releasing hormone (TRH) receptors and the in vitro stimulation of growth-hormone (GH) secretion in human GH-secreting adenomas. Le Dafniet M; Garnier P; Bression D; Brandi AM; Racadot J; Peillon F Horm Metab Res; 1985 Sep; 17(9):476-9. PubMed ID: 2864309 [TBL] [Abstract][Full Text] [Related]
24. Effect of dexamethasone on growth hormone (GH) response to growth hormone releasing hormone in acromegaly. Nakagawa K; Akikawa K; Matsubara M; Kubo M J Clin Endocrinol Metab; 1985 Feb; 60(2):306-10. PubMed ID: 3917458 [TBL] [Abstract][Full Text] [Related]
25. Different responses of growth hormone secretion to guanfacine, bromocriptine, and thyrotropin-releasing hormone in acromegalic patients with pure growth hormone (GH)-containing and mixed GH/prolactin-containing pituitary adenomas. Lamberts SW; Klijn JG; van Vroonhoven CC; Stefanko SZ J Clin Endocrinol Metab; 1985 Jun; 60(6):1148-53. PubMed ID: 3923021 [TBL] [Abstract][Full Text] [Related]
26. Secretory mechanisms of growth hormone (GH)-releasing peptide-, GH-releasing hormone-, and thyrotropin-releasing hormone-induced GH release in patients with acromegaly. Hanew K; Utsumi A; Tanaka A; Ikeda H; Yokogoshi Y J Clin Endocrinol Metab; 1998 Oct; 83(10):3578-83. PubMed ID: 9768668 [TBL] [Abstract][Full Text] [Related]
27. The growth hormone (GH)-axis of GH receptor/binding protein gene-disrupted and metallothionein-human GH-releasing hormone transgenic mice: hypothalamic neuropeptide and pituitary receptor expression in the absence and presence of GH feedback. Peng XD; Park S; Gadelha MR; Coschigano KT; Kopchick JJ; Frohman LA; Kineman RD Endocrinology; 2001 Mar; 142(3):1117-23. PubMed ID: 11181526 [TBL] [Abstract][Full Text] [Related]
28. Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects. Gola M; Doga M; Bonadonna S; Mazziotti G; Vescovi PP; Giustina A Pituitary; 2006; 9(3):221-9. PubMed ID: 17036195 [TBL] [Abstract][Full Text] [Related]
29. Somatostatin receptors on thyrotropin-secreting pituitary adenomas: comparison with the inhibitory effects of octreotide upon in vivo and in vitro hormonal secretions. Bertherat J; Brue T; Enjalbert A; Gunz G; Rasolonjanahary R; Warnet A; Jaquet P; Epelbaum J J Clin Endocrinol Metab; 1992 Aug; 75(2):540-6. PubMed ID: 1353505 [TBL] [Abstract][Full Text] [Related]
30. Heterogeneity of pituitary adenoma cell subpopulations from acromegalic patients obtained by Percoll density gradient centrifugation. Hofland LJ; van Koetsveld PM; Verleun TM; Lamberts SW Acta Endocrinol (Copenh); 1989 Aug; 121(2):270-8. PubMed ID: 2549755 [TBL] [Abstract][Full Text] [Related]
31. Secretion of glycoprotein hormone alpha-subunit by pituitary tumors. Ishibashi M; Yamaji T; Takaku F; Teramoto A; Fukushima T J Clin Endocrinol Metab; 1987 Jun; 64(6):1187-93. PubMed ID: 2437140 [TBL] [Abstract][Full Text] [Related]
32. Growth hormone (GH)-releasing hormone tonically inhibits in vitro endogenous somatostatin in human GH-secreting tumors. Mouhieddine OE; Levy L; Benlot C; Peillon F; Joubert D J Clin Endocrinol Metab; 1995 May; 80(5):1691-5. PubMed ID: 7745020 [TBL] [Abstract][Full Text] [Related]
33. Ectopic secretion of growth hormone-releasing hormone (GHRH) in neuroendocrine tumors: relevant clinical aspects. Doga M; Bonadonna S; Burattin A; Giustina A Ann Oncol; 2001; 12 Suppl 2():S89-94. PubMed ID: 11762359 [TBL] [Abstract][Full Text] [Related]
34. High density of somatostatin receptors in pituitary tumors from acromegalic patients. Reubi JC; Landolt AM J Clin Endocrinol Metab; 1984 Dec; 59(6):1148-51. PubMed ID: 6092412 [TBL] [Abstract][Full Text] [Related]
35. The expression of thyrotrophin-releasing hormone receptor 1 messenger ribonucleic acid in human pituitary adenomas. Kim K; Arai K; Sanno N; Teramoto A; Shibasaki T Clin Endocrinol (Oxf); 2001 Mar; 54(3):309-16. PubMed ID: 11298082 [TBL] [Abstract][Full Text] [Related]
36. Glycoprotein hormone alpha-subunit and prolactin release by cultured pituitary adenoma cells from acromegalic patients: correlation with GH release. Hofland LJ; van Koetsveld PM; Verleun TM; Lamberts SW Clin Endocrinol (Oxf); 1989 Jun; 30(6):601-11. PubMed ID: 2512040 [TBL] [Abstract][Full Text] [Related]
37. Growth hormone (GH) and prolactin responses to repetitive administration of GH-releasing hormone in acromegaly. Losa M; Schopohl J; König A; Müller OA; von Werder K J Clin Endocrinol Metab; 1986 Aug; 63(2):475-80. PubMed ID: 3088026 [TBL] [Abstract][Full Text] [Related]
38. Secretion of growth hormone (GH)-releasing hormone by GH-producing pituitary adenoma assessed by cell immunoblot analysis. Kawamoto K; Uozumi T; Arita K; Takechi A; Kawamoto H Endocr J; 1995 Feb; 42(1):89-93. PubMed ID: 7599704 [TBL] [Abstract][Full Text] [Related]
39. The GH-releasing hormone (GHRH) test in acromegaly before and after adenomectomy. Giusti M; Lomeo A; Monachesi M; Mazzocchi G; Attanasio R; Sessarego P; Mignone D; Del Monte P; Giordano G J Endocrinol Invest; 1987 Apr; 10(2):143-51. PubMed ID: 3108356 [TBL] [Abstract][Full Text] [Related]
40. Effect of acute pharmacological modulation of plasma free fatty acids on GH secretion in acromegalic patients. Cordido F; Peñalva A; Martinez T; Casanueva FF; Dieguez C Clin Endocrinol (Oxf); 2001 Apr; 54(4):509-13. PubMed ID: 11318787 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]